Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis

被引：0
|
作者：
Sibel Ada
Sibel Ersan
Aykut Sifil
Mehtat Unlu
Efsun Kolatan
Mehmet Sert
Sulen Sarioglu
Osman Yilmaz
Taner Camsari
机构：
[1] Dokuz Eylul University Hospital,Division of Nephrology, Department of Internal Medicine
[2] Dokuz Eylul University Hospital,Department of Pathology
[3] Dokuz Eylul University Hospital,Department of Laboratory Animals Science
来源：
International Urology and Nephrology | 2015年 / 47卷
关键词：
Fibrosis; Growth factors; Peritoneal dialysis; Peritoneal membrane;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2047 / 2051
页数：4
相关论文
共 50 条
  • [31] The combinatory effect of Bevacizumab and telomerase inhibitors on vascular endothelial growth factor secretion in gastrointestinal cancers
    Mahfouz, N.
    Tahtouh, R.
    Sarkis, R.
    Bdeiri, K.
    Alaaeddine, N.
    Hilal, G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S403 - S403
  • [32] Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors
    Goldlust, Samuel A.
    Cavaliere, Robert
    Newton, Herbert B.
    Hsu, Meier
    DeAngelis, Lisa M.
    Batchelor, Tracy T.
    Gilbert, Mark R.
    Lassman, Andrew B.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (02) : 407 - 411
  • [33] Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors
    Samuel A. Goldlust
    Robert Cavaliere
    Herbert B. Newton
    Meier Hsu
    Lisa M. DeAngelis
    Tracy T. Batchelor
    Mark R. Gilbert
    Andrew B. Lassman
    Journal of Neuro-Oncology, 2012, 107 : 407 - 411
  • [34] Protective effect of vascular endothelial growth factor/vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the rat
    Miyamoto, K
    Kitamoto, Y
    Tokunaga, H
    Takeya, M
    Ezaki, T
    Imamura, T
    Tomita, K
    LABORATORY INVESTIGATION, 2004, 84 (09) : 1126 - 1136
  • [35] Reply: Effect of Endogenous Vascular Endothelial Growth Factor on Flap Surgical Delay in a Rat Flap Model
    Jiang, Zhenmin
    Gong, Xu
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2019, 144 (06) : 1117e - 1117e
  • [36] Vascular endothelial growth factor receptor-2 inhibitor cediranib causes regression of endometriotic lesions in a rat model
    Liu, Fang
    Wang, Li
    Zhang, Xian-Xia
    Min, Shu-Yun
    Liu, Yi-Xuan
    Zuo, Zhi
    Jin, Zhi-Xing
    Zhu, Zhi-Ling
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (02): : 1165 - 1174
  • [37] Patients with Encapsulating Peritoneal Sclerosis Have Increased Peritoneal Expression of Connective Tissue Growth Factor (CCN2), Transforming Growth Factor-β1, and Vascular Endothelial Growth Factor
    Abrahams, Alferso C.
    Habib, Sayed M.
    Dendooven, Amelie
    Riser, Bruce L.
    van der Veer, Jan Willem
    Toorop, Raechel J.
    Betjes, Michiel G. H.
    Verhaar, Marianne C.
    Watson, Christopher J. E.
    Nguyen, Tri Q.
    Boer, Walther H.
    PLOS ONE, 2014, 9 (11):
  • [38] EFFECT OF INTRAARTICULAR INJECTION OF VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITOR ON OSTEOCHONDRAL UNIT IN SURGICAL OSTEOARTHRITIS RATS MODEL
    Okuno, Yu
    Nagira, Keita
    Osaki, Mitsuhiko
    Hayashi, Ikuta
    Kanaya, Haruhisa
    Hagino, Hiroshi
    Nagashima, Hideki
    OSTEOARTHRITIS AND CARTILAGE, 2024, 32 : S277 - S278
  • [39] Effect of cediranib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, in a mouse model of choroidal neovascularization
    Kang, Seungbum
    Park, Ki Cheol
    Yang, Keum-Jin
    Choi, Hyun-Su
    Kim, So-Hee
    Roh, Young-Jung
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 (01): : 63 - 72
  • [40] Effect of hyperoxia on vascular endothelial growth factor levels in a wound model
    Sheikh, AY
    Gibson, JJ
    Rollins, MD
    Hopf, HW
    Hussain, Z
    Hunt, TK
    ARCHIVES OF SURGERY, 2000, 135 (11) : 1293 - 1297
12345